Does RITUXIMAB Cause Myelosuppression? 1,436 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,436 reports of Myelosuppression have been filed in association with RITUXIMAB (Rituxan). This represents 0.8% of all adverse event reports for RITUXIMAB.
1,436
Reports of Myelosuppression with RITUXIMAB
0.8%
of all RITUXIMAB reports
179
Deaths
647
Hospitalizations
How Dangerous Is Myelosuppression From RITUXIMAB?
Of the 1,436 reports, 179 (12.5%) resulted in death, 647 (45.1%) required hospitalization, and 179 (12.5%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 1,436 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which RITUXIMAB Alternatives Have Lower Myelosuppression Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE